What is Chemical Works of Gedeon Richter PB Ratio?
Chemical Works of Gedeon RichterRGEDF -1.78%94 PB Ratio is 1.58 as of Jun. 27, 2026, which is 2% above its 10-year median of 1.55. GuruFocus rates RGEDF with a GF Score™ of 94/100 and a GF Value™ of $36.19 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 922 Drug Manufacturers companies, Chemical Works of Gedeon Richter ranks better than 56.72% on this metric.
RGEDF'
s PB Ratio Range Over the Past 10 Years
Min: 1.21 Med: 1.55 Max: 2.05
Current: 1.6
During the past 13 years, Chemical Works of Gedeon Richter's highest PB Ratio was 2.05. The lowest was 1.21. And the median was 1.55.
RGEDF's PB Ratio is ranked better than 56.72% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.825
vs RGEDF: 1.60
During the past 12 months, Chemical Works of Gedeon Richter's average Book Value Per Share Growth Rate was 7.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 10.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 12.20% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 9.20% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Chemical Works of Gedeon Richter was 13.90% per year. The lowest was 2.00% per year. And the median was 10.30% per year.
Back to Basics: PB Ratio
Chemical Works of Gedeon Richter (OTCPK:RGEDF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Chemical Works of Gedeon Richter PB Ratio Related Terms
Chemical Works of Gedeon Richter PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Chemical Works of Gedeon Richter's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chemical Works of Gedeon Richter PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Chemical Works of Gedeon Richter's PB Ratio distribution charts can be found below:
* The bar in red indicates where Chemical Works of Gedeon Richter's PB Ratio falls into.
Chemical Works of Gedeon Richter PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Chemical Works of Gedeon Richter (RGEDF) has a PB Ratio of 1.58 as of Jun. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Chemical Works of Gedeon Richter and its competitors. This is near median its historical median of 1.55. Over the past decade, Chemical Works of Gedeon Richter's PB Ratio has ranged from 1.21 to 2.05. According to the industry distribution chart, Chemical Works of Gedeon Richter ranks #399 out of 922 companies in the Drug Manufacturers industry, placing it in the top 43.3%.
Is Chemical Works of Gedeon Richter's PB Ratio too high?
Chemical Works of Gedeon Richter's current PB Ratio of 1.58 is near median its 10-year median of 1.55. Over the past 10 years, this metric has ranged from a low of 1.21 to a high of 2.05. The Drug Manufacturers industry median PB Ratio is 1.83. Chemical Works of Gedeon Richter's value of 1.58 is 13.4% below this industry median. Based on the distribution chart, Chemical Works of Gedeon Richter ranks #399 out of 922 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Chemical Works of Gedeon Richter has a GF Score™ of 94/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Chemical Works of Gedeon Richter's PB Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Chemical Works of Gedeon Richter ranks #399 out of 922 companies for PB Ratio. This puts Chemical Works of Gedeon Richter in the upper half of its industry. The industry median PB Ratio is 1.83. Chemical Works of Gedeon Richter's value of 1.58 is 13.4% below this benchmark. Historically, Chemical Works of Gedeon Richter's own PB Ratio has ranged from 1.21 to 2.05 over the past decade. While the company's 10-year median is 1.55 vs. the industry median of 1.83, Chemical Works of Gedeon Richter has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.83, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chemical Works of Gedeon Richter's current PB Ratio of 1.58 is 13.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Chemical Works of Gedeon Richter and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chemical Works of Gedeon Richter's current PB Ratio is 1.58, which is near median its own 10-year median of 1.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemical Works of Gedeon Richter stock overvalued right now?
Based on GuruFocus' analysis, Chemical Works of Gedeon Richter (RGEDF) is currently considered Modestly Overvalued. The stock's GF Value™ is $36.19, compared to a current price of $39.59 — trading 9.4% above its estimated fair value. The current PB Ratio is 1.58, which is near median its 10-year median of 1.55 and 13.4% below the Drug Manufacturers industry median of 1.83. Chemical Works of Gedeon Richter's overall GF Score™ is 94/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Chemical Works of Gedeon Richter (RGEDF), the current PB Ratio is 1.58 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chemical Works of Gedeon Richter (RGEDF) Overvalued in 2026?
Based on GuruFocus' analysis, Chemical Works of Gedeon Richter stock appears to be overvalued.
The current stock price of $39.59 is trading 9.4% above its estimated GF Value™ of $36.19.
GuruFocus considers Chemical Works of Gedeon Richter to be Modestly Overvalued.
Key valuation signals for RGEDF:
PB Ratio: 1.58 (near median its 10-year median of 1.55)
GF Value™: $36.19 vs. price of $39.59 (9.4% above fair value)
Industry Position: 13.4% below the Drug Manufacturers median (#399 of 922)
No single metric tells the full story. See the RGEDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chemical Works of Gedeon Richter Business Description
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular, and central nervous system products. It manufactures medicines including original, generic and licensed products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharma segment comprising Women's Healthcare, Neuropsychiatry, Biotechnology, General Medicine, and Other pharma; and the Others segment includes the remaining wholesale and retail business of the Group and all other activities. The company operates internationally.
94GF Score
Get the complete analysis for RGEDF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RGEDF has been successfully added to your 
